• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

β-环糊精包合物改善吡哌酸的物理化学性质:表征与生物活性评价

β-Cyclodextrin inclusion complex to improve physicochemical properties of pipemidic acid: characterization and bioactivity evaluation.

作者信息

Iacovino Rosa, Rapuano Filomena, Caso Jolanda Valentina, Russo Agostino, Lavorgna Margherita, Russo Chiara, Isidori Marina, Russo Luigi, Malgieri Gaetano, Isernia Carla

机构信息

Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, Second University of Naples, Via A. Vivaldi 43, 81100 Caserta, Italy.

出版信息

Int J Mol Sci. 2013 Jun 25;14(7):13022-41. doi: 10.3390/ijms140713022.

DOI:10.3390/ijms140713022
PMID:23799358
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3742172/
Abstract

The aptitude of cyclodextrins (CDs) to form host-guest complexes has prompted an increase in the development of new drug formulations. In this study, the inclusion complexes of pipemidic acid (HPPA), a therapeutic agent for urinary tract infections, with native β-CD were prepared in solid state by kneading method and confirmed by FT-IR and 1H NMR. The inclusion complex formation was also characterized in aqueous solution at different pH via UV-Vis titration and phase solubility studies obtaining the stability constant. The 1:1 stoichiometry was established by a Job plot and the inclusion mechanism was clarified using docking experiments. Finally, the antibacterial activity of HPPA and its inclusion complex was tested on P. aeruginosa, E. coli and S. aureus to determine the respective EC50s and EC90s. The results showed that the antibacterial activity of HPPA:β-CD against E. coli and S. aureus is higher than that of HPPA. Furthermore, HPPA and HPPA:β-CD, tested on human hepatoblastoma HepG2 and MCF-7 cell lines by MTT assay, exhibited, for the first time, antitumor activities, and the complex revealed a higher activity than that of HPPA. The use of β-CD allows an increase in the aqueous solubility of the drug, its bioavailability and then its bioactivity.

摘要

环糊精(CDs)形成主客体复合物的能力促使新型药物制剂的开发不断增加。在本研究中,采用捏合法固态制备了用于治疗尿路感染的药物吡哌酸(HPPA)与天然β-环糊精的包合物,并通过傅里叶变换红外光谱(FT-IR)和核磁共振氢谱(1H NMR)进行了确证。还通过紫外可见滴定法和相溶解度研究在不同pH的水溶液中对包合物的形成进行了表征,获得了稳定常数。通过Job曲线确定了1:1的化学计量比,并使用对接实验阐明了包合机制。最后,对HPPA及其包合物对铜绿假单胞菌、大肠杆菌和金黄色葡萄球菌的抗菌活性进行了测试,以确定各自的半数有效浓度(EC50)和90%有效浓度(EC90)。结果表明,HPPA:β-环糊精对大肠杆菌和金黄色葡萄球菌的抗菌活性高于HPPA。此外,通过MTT法在人肝癌HepG2和MCF-7细胞系上测试的HPPA和HPPA:β-环糊精首次表现出抗肿瘤活性,且该复合物的活性高于HPPA。β-环糊精的使用提高了药物的水溶性、生物利用度及其生物活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a97/3742172/4a3ee812c943/ijms-14-13022f12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a97/3742172/9845beedd922/ijms-14-13022f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a97/3742172/bcc21efa932b/ijms-14-13022f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a97/3742172/92a082f1ace3/ijms-14-13022f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a97/3742172/579cae211a5e/ijms-14-13022f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a97/3742172/316f5bbc18f5/ijms-14-13022f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a97/3742172/618a7a892ca6/ijms-14-13022f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a97/3742172/e1b740188dea/ijms-14-13022f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a97/3742172/409535498dbe/ijms-14-13022f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a97/3742172/f311b73795b0/ijms-14-13022f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a97/3742172/87708957ed50/ijms-14-13022f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a97/3742172/28b1d973699a/ijms-14-13022f11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a97/3742172/4a3ee812c943/ijms-14-13022f12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a97/3742172/9845beedd922/ijms-14-13022f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a97/3742172/bcc21efa932b/ijms-14-13022f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a97/3742172/92a082f1ace3/ijms-14-13022f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a97/3742172/579cae211a5e/ijms-14-13022f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a97/3742172/316f5bbc18f5/ijms-14-13022f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a97/3742172/618a7a892ca6/ijms-14-13022f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a97/3742172/e1b740188dea/ijms-14-13022f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a97/3742172/409535498dbe/ijms-14-13022f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a97/3742172/f311b73795b0/ijms-14-13022f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a97/3742172/87708957ed50/ijms-14-13022f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a97/3742172/28b1d973699a/ijms-14-13022f11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a97/3742172/4a3ee812c943/ijms-14-13022f12.jpg

相似文献

1
β-Cyclodextrin inclusion complex to improve physicochemical properties of pipemidic acid: characterization and bioactivity evaluation.β-环糊精包合物改善吡哌酸的物理化学性质:表征与生物活性评价
Int J Mol Sci. 2013 Jun 25;14(7):13022-41. doi: 10.3390/ijms140713022.
2
A New Approach for Improving the Antibacterial and Tumor Cytotoxic Activities of Pipemidic Acid by Including It in Trimethyl-β-cyclodextrin.一种将哌拉西林酸包合于三甲基-β-环糊精中以提高其抗菌和肿瘤细胞毒性活性的新方法。
Int J Mol Sci. 2019 Jan 18;20(2):416. doi: 10.3390/ijms20020416.
3
Characterization of Complexes between Imidacloprid and β-Cyclodextrin: Evaluation of the Toxic Activity in Algae and Rotifers.拟除虫菊酯与β-环糊精配合物的特性:对藻类和轮虫的毒性活性评价。
Molecules. 2023 Mar 29;28(7):3049. doi: 10.3390/molecules28073049.
4
Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes.通过形成西洛他唑包合物提高其口服生物利用度。
AAPS PharmSciTech. 2009;10(2):660-9. doi: 10.1208/s12249-009-9249-7. Epub 2009 May 21.
5
Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.他达拉非与天然及化学修饰的β-环糊精的包合物。I:制备及体外评价
Eur J Pharm Biopharm. 2008 Nov;70(3):819-27. doi: 10.1016/j.ejpb.2008.06.024. Epub 2008 Jul 4.
6
Encapsulation of essential oil components with methyl-β-cyclodextrin using ultrasonication: Solubility, characterization, DPPH and antibacterial assay.超声法用甲基-β-环糊精包合精油成分:溶解度、表征、DPPH 和抑菌试验。
Ultrason Sonochem. 2020 Jun;64:104997. doi: 10.1016/j.ultsonch.2020.104997. Epub 2020 Feb 7.
7
Encapsulation of Risperidone by Methylated β-Cyclodextrins: Physicochemical and Molecular Modeling Studies.甲氧基-β-环糊精包合利培酮的理化性质及分子模拟研究。
Molecules. 2020 Dec 3;25(23):5694. doi: 10.3390/molecules25235694.
8
Preparation and characterization of inclusion complex of norflurazon and beta-cyclodextrin to improve herbicide formulations.为改善除草剂配方制备并表征去草净与β-环糊精的包合物
J Agric Food Chem. 2004 Feb 25;52(4):864-9. doi: 10.1021/jf0350358.
9
Physico-chemical characterization and antibacterial activity of inclusion complexes of Hyptis martiusii Benth essential oil in β-cyclodextrin.Hyptis martiusii Benth 精油-β-环糊精包合物的理化性质表征及抑菌活性
Biomed Pharmacother. 2017 May;89:201-207. doi: 10.1016/j.biopha.2017.01.158. Epub 2017 Feb 20.
10
Physicochemical characterization and cytotoxic activity evaluation of hydroxymethylferrocene:β-cyclodextrin inclusion complex.羟甲基二茂铁-β-环糊精包合物的理化性质表征及细胞毒性评价。
Molecules. 2012 May 21;17(5):6056-70. doi: 10.3390/molecules17056056.

引用本文的文献

1
Cyclodextrin-Polymethylsilsesquioxane Combined System as a Perspective Iron Delivery System for Oral Administration.环糊精-聚甲基倍半硅氧烷复合体系作为一种有前景的口服铁递送系统
Gels. 2024 Aug 30;10(9):564. doi: 10.3390/gels10090564.
2
An aerosol nanocomposite microparticle formulation using rifampicin-cyclodextrin inclusion complexes for the treatment of pulmonary diseases.一种使用利福平-环糊精包合物的气溶胶纳米复合微粒制剂,用于治疗肺部疾病。
Int J Pharm. 2024 Nov 15;665:124755. doi: 10.1016/j.ijpharm.2024.124755. Epub 2024 Sep 24.
3
Characterization of Complexes between Imidacloprid and β-Cyclodextrin: Evaluation of the Toxic Activity in Algae and Rotifers.

本文引用的文献

1
The program XEASY for computer-supported NMR spectral analysis of biological macromolecules.用于生物大分子的计算机支持的 NMR 光谱分析的 XEASY 程序。
J Biomol NMR. 1995 Jul;6(1):1-10. doi: 10.1007/BF00417486.
2
Physicochemical characterization and cytotoxic activity evaluation of hydroxymethylferrocene:β-cyclodextrin inclusion complex.羟甲基二茂铁-β-环糊精包合物的理化性质表征及细胞毒性评价。
Molecules. 2012 May 21;17(5):6056-70. doi: 10.3390/molecules17056056.
3
Pharmaceutical applications of cyclodextrins: effects on drug permeation through biological membranes.
拟除虫菊酯与β-环糊精配合物的特性:对藻类和轮虫的毒性活性评价。
Molecules. 2023 Mar 29;28(7):3049. doi: 10.3390/molecules28073049.
4
Palladium Schiff base complex-modified Cu(BDC-NH) metal-organic frameworks for C-N coupling.用于C-N偶联的钯席夫碱配合物修饰的Cu(BDC-NH)金属有机框架
RSC Adv. 2023 Mar 13;13(12):8114-8129. doi: 10.1039/d3ra01020a. eCollection 2023 Mar 8.
5
Inclusions of Pesticides by β-Cyclodextrin in Solution and Solid State: Chlorpropham, Monuron, and Propanil.β-环糊精在溶液和固态中的农药包合物:氯普罗磷、灭草隆和丙草胺。
Molecules. 2023 Jan 30;28(3):1331. doi: 10.3390/molecules28031331.
6
Cyclodextrin Inclusion Complexes with Antibiotics and Antibacterial Agents as Drug-Delivery Systems-A Pharmaceutical Perspective.环糊精与抗生素及抗菌剂形成的包合物作为药物递送系统——药学视角
Pharmaceutics. 2022 Jun 30;14(7):1389. doi: 10.3390/pharmaceutics14071389.
7
Thermal Degradation of Linalool-Chemotype Leaf Essential Oil and Its Stabilization by Microencapsulation with β-Cyclodextrin.芳樟醇型叶用精油的热降解及其用β-环糊精微胶囊化的稳定化作用。
Molecules. 2021 Jan 14;26(2):409. doi: 10.3390/molecules26020409.
8
Stoichiometrically Governed Curcumin Solid Dispersion and Its Cytotoxic Evaluation on Colorectal Adenocarcinoma Cells.化学计量控制的姜黄素固体分散体及其对结直肠腺癌细胞的细胞毒性评价。
Drug Des Devel Ther. 2020 Nov 2;14:4639-4658. doi: 10.2147/DDDT.S273322. eCollection 2020.
9
Polypseudorotaxanes of Pluronic® F127 with Combinations of α- and β-Cyclodextrins for Topical Formulation of Acyclovir.聚氧乙烯聚氧丙烯共聚物F127与α-和β-环糊精组合形成的聚准轮烷用于阿昔洛韦的局部制剂
Nanomaterials (Basel). 2020 Mar 27;10(4):613. doi: 10.3390/nano10040613.
10
Effect of antioxidant activity of caffeic acid with cyclodextrins using ground mixture method.采用研磨混合法研究咖啡酸与环糊精的抗氧化活性效应。
Asian J Pharm Sci. 2018 Jan;13(1):24-33. doi: 10.1016/j.ajps.2017.08.006. Epub 2017 Oct 14.
环糊精在药物制剂中的应用:对药物穿透生物膜的影响。
J Pharm Pharmacol. 2011 Sep;63(9):1119-35. doi: 10.1111/j.2042-7158.2011.01279.x. Epub 2011 Apr 4.
4
Pharmaceutical composition of hydrochlorothiazide:β-cyclo-dextrin: preparation by three different methods, physico-chemical characterization and in vivo diuretic activity evaluation.氢氯噻嗪的药物组合物:β-环糊精:通过三种不同方法制备、物理化学特性描述和体内利尿活性评价。
Molecules. 2011 May 27;16(6):4482-99. doi: 10.3390/molecules16064482.
5
Selective cytotoxicity of goniothalamin against hepatoblastoma HepG2 cells.岗柃亭对肝癌 HepG2 细胞的选择性细胞毒性。
Molecules. 2011 Apr 6;16(4):2944-59. doi: 10.3390/molecules16042944.
6
Optimal methods for evaluating antimicrobial activities from plant extracts.植物提取物抗菌活性的最佳评价方法。
J Microbiol Methods. 2011 Feb;84(2):161-6. doi: 10.1016/j.mimet.2010.11.008. Epub 2010 Nov 18.
7
Ultra-fast FFT protein docking on graphics processors.基于图形处理器的超快 FFT 蛋白质对接。
Bioinformatics. 2010 Oct 1;26(19):2398-405. doi: 10.1093/bioinformatics/btq444. Epub 2010 Aug 4.
8
Experimental and clinical studies on fluoroquinolone-insusceptible Escherichia coli isolated from patients with urinary tract infections from 1994 to 2007.1994年至2007年从尿路感染患者中分离出的氟喹诺酮不敏感大肠埃希菌的实验与临床研究
Acta Med Okayama. 2009 Oct;63(5):263-72. doi: 10.18926/AMO/31836.
9
CHM-1, a novel synthetic quinolone with potent and selective antimitotic antitumor activity against human hepatocellular carcinoma in vitro and in vivo.CHM-1,一种新型合成喹诺酮类药物,在体外和体内对人肝细胞癌具有强效且选择性的抗有丝分裂抗肿瘤活性。
Mol Cancer Ther. 2008 Feb;7(2):350-60. doi: 10.1158/1535-7163.MCT-07-2000.
10
Quinolone analogue inhibits tubulin polymerization and induces apoptosis via Cdk1-involved signaling pathways.喹诺酮类似物通过涉及细胞周期蛋白依赖性激酶1(Cdk1)的信号通路抑制微管蛋白聚合并诱导细胞凋亡。
Biochem Pharmacol. 2007 Jun 30;74(1):10-9. doi: 10.1016/j.bcp.2007.03.015. Epub 2007 Mar 24.